Clinical Trials Logo

Filter by:
NCT ID: NCT04778410 Completed - Clinical trials for Myeloid Malignancies

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Start date: June 28, 2021
Phase: Phase 2
Study type: Interventional

The goal of this clinical study is to learn more about the safety and dosing of the study drug, magrolimab (Mag), in combination with anti-leukemia therapies in participants with acute myeloid leukemia (AML).

NCT ID: NCT04777877 Completed - Chronic Pain Clinical Trials

PNE Delivered With a VR Headset in Outpatient LBP Patients

Start date: February 18, 2021
Phase:
Study type: Observational

The primary objective of this study is to explore the feasibility and acceptability of the delivery of educational content using a virtual reality headset in the setting of an outpatient physical therapy (PT) course of care for chronic low back pain. We aim to collect both qualitative and quantitative data regarding: 1) specifics of device use in the course of PT care 2) acceptability of both the content and delivery method from the therapist and subject perspective 3) subject attributes to characterize the study population and explore possible associations with content responses and 4) changes in pain knowledge from pre to post intervention. Information learned in this pilot study will assist us in 1) improving the content and delivery method of a chronic pain education program 2) implementing the program across the Spaulding rehabilitation network and 3) designing a more rigorous effectiveness trial.

NCT ID: NCT04777864 Completed - Concussion, Brain Clinical Trials

Developing a Tool to Support Shared Decision Making Post-Concussion Between Adolescents, Parents and Clinicians

Start date: August 30, 2021
Phase: N/A
Study type: Interventional

Investigators will conduct a pilot efficacy test of a decision aid about contact sport participation post-concussion.

NCT ID: NCT04777695 Completed - Noise Exposure Clinical Trials

Sound Levels in the Pediatric Cardiac Critical Care Unit and Their Correlation With Sedation Administration, Delirium Scores and Patient Heart Rate

Start date: March 1, 2021
Phase:
Study type: Observational

There is limited data regarding sound levels and burden in the pediatric cardiac critical care unit and how this compares with WHO standards. We seek to record this data and correlate sound level with bolus sedation administration, patient delirium scores, and patient heart rate trends. Primary Outcomes - 1 peak sound level in cardiac ICU in decibels - 2 Mean sound level in cardiac ICU in decibels - 3 Compare sound levels to WHO recommendations Secondary Outcomes - 1 To explore patient and unit factors that might influence these levels - 2 To analyze sound levels in post-operative neonates, versus infants, versus children - 3 To analyze patients on invasive versus non-invasine versus no ventilation

NCT ID: NCT04777643 Completed - CBD Clinical Trials

Sex Differences in Neural Response to Cannabidiol

Start date: June 7, 2022
Phase: Early Phase 1
Study type: Interventional

This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.

NCT ID: NCT04777370 Completed - Range of Motion Clinical Trials

Combined Effects of Manual Therapy on the Shoulder

Start date: March 31, 2021
Phase: N/A
Study type: Interventional

Interventions including glenohumeral mobilization, sleeper stretches, and thoracic manipulation have been proposed for individuals with loss of shoulder range of motion (ROM). However, the effect of these interventions on shoulder ROM, joint translation, and muscular activity have not been studied in combination.

NCT ID: NCT04777344 Completed - Cystic Fibrosis Clinical Trials

Clinical Effort Against Smoke Exposure in Cystic Fibrosis

CEASE-CF
Start date: July 8, 2021
Phase: N/A
Study type: Interventional

The study will test the feasibility, acceptability, and preliminary efficacy of a multi-component smoking cessation intervention tailored to the needs of caregivers of children with CF and delivered in clinical settings as part of routine CF care. The ultimate goal of this effort is to reduce the exposure of children and adolescents with CF to tobacco smoke.

NCT ID: NCT04777214 Completed - Aphasia Clinical Trials

TMS in Aphasia Recovery

Start date: June 26, 2007
Phase: N/A
Study type: Interventional

Stroke often causes substantial problems in speaking or understanding speech. Treatments for these problems are currently very limited. Limited studies to date suggest that repetitive Transcranial Magnetic Stimulation (TMS) to the side of the brain opposite to the side on which the stroke occurred may improve language function. The investigators are testing this hypothesis by giving daily 20 minute sessions of repeated TMS to the right (unaffected) side of the brain; the investigators test language function with a variety of tests both before and after the treatment with TMS and subjects are required to undergo functional MRI scans before and after treatment. TMS is a procedure in which a coil is placed next to the head of the subject and an electrical current passes through the coil causing a magnetic field that, in turn, causes a small electric current in the portion of the brain underneath the coil.

NCT ID: NCT04777149 Completed - Clinical trials for Spinal Cord Injuries

Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

Cervical spinal cord injury (SCI) results in hand and arm function impairments and decreased independence in performance of daily activities such as bathing, eating, dressing, writing, or typing. Recent approaches that involve the application of non-invasive brain stimulation have the potential to strengthen the remaining connections between the brain and the spinal cord for improved hand function. Combining brain stimulation with performing upper limb functional tasks may further increase the ability of individuals with tetraplegia to use their hands. The purpose of this study is to investigate if "random noise", a special type of brain stimulation that most people cannot feel, can be used to enhance upper limb function in individuals with spinal cord injury. Specifically, the investigators will examine if a combined treatment protocol of random noise and fine motor training results in greater improvements in motor and sensory hand function compared to fine motor training alone.

NCT ID: NCT04776967 Completed - Pressure Injury Clinical Trials

Effect of Total Compression Time and Rate (Slope) on Incidence of Symptomatic ETD and MEB: A Phase II Prospective Study.

Start date: September 8, 2014
Phase: N/A
Study type: Interventional

Eustachian tube dysfunction (ETD) and middle ear barotrauma (MEB) are common reported complications during hyperbaric oxygen treatment. The Phase I study data was the first to demonstrate a statistically significant decrease in the occurrence of symptomatic ETD and middle ear barotrauma (MEB). The Phase I Trial suggested the total time interval and rate (slope) of compression (ROC) may be a determining factor in ETD and MEB. This Phase II study investigates an optimal total time interval and rate of compression to reduce ETD and MEB when considering each multiplace treatment (with multiple patients) as the unit of observation collectively as a group, rather than for each individual patient. Data will be collected prospectively on group patient-treatment exposures. The investigators randomly assigned patient-treatment group exposures to four different time interval and rate (slope) of compression. These total time intervals of compression and rates (slopes) of compression are identical to those used in the Phase I trial. All patients experiencing symptoms of ETD and MEB requiring compression stops will be evaluated post treatment to confirm the presence of ETD and MEB using the O'Neill Grading System (OGS). Data will be analyzed using the IBM-SPSS statistical software program. The number of compression holds observed in each of the 4 compression schedules, similar to ther Phase I trial will be recorded. Patients who are symptomatic and require compression stops (as in the Phase I trial) using a United States Navy Treatment Table 9 (USN-TTN9) during elective hyperbaric oxygen treatments in a Class A multiplace hyperbaric chamber will be analyzed. Analysis using descriptive and inferential statistics will be applied to the patients requiring first stops in the 4 compression profiles. This Phase II study increases the sample size of treatments and they will be combined with the total number of treatments used in the original phase I study. This will increase power to facilitate detailed descriptive analysis and to determine if the findings are robust in the phase I study.